PURPOSE: To evaluate the usefulness of hydrogen-1 magnetic resonance (MR) spectroscopy in the evaluation of the developing brain. MATERIALS AND METHODS: Localized MR spectra were obtained with an echo time of 272 msec from the brain of 78 neonates and infants aged 1 week to 100 months. All patients were retrospectively classified into three groups on the basis of neurologic development: abnormal (group 2, n = 21), normal despite minor neurologic signs (group 1, n = 23), and normal (group 0, n = 34). RESULTS: Seventeen patients in group 2 and eight patients in group 1 revealed abnormally low N-acetylaspartate (NAA)/choline or NAA/creatine ratios compared with those obtained in group 0. MR spectroscopy was slightly more useful in the differentiation of patients in groups 2 and 1 (chi 2 test, P < .005) than MR imaging (P < .01). CONCLUSION: H-1 MR spectroscopy provides prognostic information about the brain in healthy and neurologically damaged infants and augments the value of MR imaging.
PURPOSE: To evaluate the usefulness of hydrogen-1 magnetic resonance (MR) spectroscopy in the evaluation of the developing brain. MATERIALS AND METHODS: Localized MR spectra were obtained with an echo time of 272 msec from the brain of 78 neonates and infants aged 1 week to 100 months. All patients were retrospectively classified into three groups on the basis of neurologic development: abnormal (group 2, n = 21), normal despite minor neurologic signs (group 1, n = 23), and normal (group 0, n = 34). RESULTS: Seventeen patients in group 2 and eight patients in group 1 revealed abnormally low N-acetylaspartate (NAA)/choline or NAA/creatine ratios compared with those obtained in group 0. MR spectroscopy was slightly more useful in the differentiation of patients in groups 2 and 1 (chi 2 test, P < .005) than MR imaging (P < .01). CONCLUSION: H-1 MR spectroscopy provides prognostic information about the brain in healthy and neurologically damaged infants and augments the value of MR imaging.
Authors: Duan Xu; Sonia L Bonifacio; Natalie N Charlton; Charles P Vaughan; Ying Lu; Donna M Ferriero; Daniel B Vigneron; A James Barkovich Journal: J Magn Reson Imaging Date: 2011-02 Impact factor: 4.813
Authors: Soo Mee Lim; Hye-Young Choi; Jung Soo Suh; Jung Hee Lee; Keun Ho Lim; Dae Chul Suh; Ho Kyu Lee; Tae-Hwan Lim; Young Shin Ra Journal: Korean J Radiol Date: 2003 Apr-Jun Impact factor: 3.500
Authors: Eva H Baker; Gianpaolo Basso; Peter B Barker; Mari A Smith; David Bonekamp; Alena Horská Journal: J Magn Reson Imaging Date: 2008-03 Impact factor: 4.813
Authors: Christopher G Filippi; Aziz M Uluğ; Michael D F Deck; Robert D Zimmerman; Linda A Heier Journal: AJNR Am J Neuroradiol Date: 2002-05 Impact factor: 3.825
Authors: Dong-Hyun Kim; Meng Gu; Charles Cunningham; Albert Chen; Fiona Baumer; Orit A Glenn; Daniel B Vigneron; Daniel Mark Spielman; Anthony James Barkovich Journal: J Magn Reson Imaging Date: 2009-01 Impact factor: 4.813
Authors: Artemis D Gika; Ata Siddiqui; Anthony J Hulse; Selvakumari Edward; Penny Fallon; Meriel E McEntagart; Wajanat Jan; Dragana Josifova; Tally Lerman-Sagie; James Drummond; Edward Thompson; Samuel Refetoff; Carsten G Bönnemann; Heinz Jungbluth Journal: Dev Med Child Neurol Date: 2009-10-07 Impact factor: 5.449